Figure 11.
Immunotherapeutic and chemotherapeutic responses for high- and low-risk patients. (A) Boxplots illustrate the immunotherapeutic and chemotherapeutic responses of Cisplatin, Gefitinib, Gemcitabine, and Sorafenib in the high- and low-risk patients. (B) Boxplots illustrate the immunotherapeutic and chemotherapeutic responses of Vinblastine, Vinorelbine, Vorinostat, and Sunitinib in the high- and low-risk patients. Significance: ns≥0.05, ∗<0.05, ∗∗<0.01, ∗∗∗<0.001, and ∗∗∗∗<0.0001.